Fluvoxamine Treatment and D2 Receptors: a Pet Study on OCD Drug-Naïve Patients
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Changes in D(2) receptors during antidepressant therapy have been reported in patients with major depressive disorder using PET/SPET. The aim of this study was to evaluate modifications in D(2) receptors that might occur in patients affected by obsessive-compulsive disorder (OCD) during serotonin reuptake sites inhibitors (SSRIs). To this purpose, we measured the in vivo binding of [(11)C]raclopride ([(11)C]Rac)in the brain of a group of OCD naïve patients before and after the repeated administration of the inhibitor SSRI fluvoxamine. Eight patients with a Diagnostic and Statistical Manual of Mental Disorders IVth edition diagnosis of OCD completed the study undergoing a PET scan and a complete clinical evaluation before and during treatment with fluvoxamine. Patients have been compared also with a group of nine age-matched normal volunteers. Fluvoxamine treatment significantly improved clinical symptoms and increased [(11)C]Rac binding potential (BP) in the basal ganglia of OCD patients (7.5+/-5.2, 6.9+/-6.9, and 9.9+/-9.3% in dorsal caudate, dorsal putamen, and ventral basal ganglia, respectively; p<0.01) to values closer to those observed in the group of normal subjects. Chronic treatment with fluvoxamine induces a slight but significant increase in striatal [(11)C]Rac BP of previously drug-naïve OCD patients. The modifications in D(2) receptor availability might be secondary to fluvoxamine effects on serotoninergic activity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“a system apparently impaired in OCD (Denys et al. 2004; Hesse et al. 2005; Moresco et al. 2007; Olver et al. 2009, 2010; Perani et al. 2008; Sesia et al. 2013; Van Der Wee et al. 2004)”
From Dopaminergic drug treatment remediates exaggerated cingulate prediction error responses in obsessive-compulsive disorder (2019) · cites this paper as Moresco et al. 2007
In the citing paper
“Evidence from human molecular imaging studies of patients with OCD suggests a possible role for dopaminergic pathology in OCD (Denys et al. 2004; Hesse et al. 2005; Moresco et al. 2007; Olver et al. 2009, 2010; Perani et al. 2008; Sesia et al. 2013; Van Der Wee et al. 2004).”
From Dopaminergic drug treatment remediates exaggerated cingulate prediction error responses in obsessive-compulsive disorder (2019) · cites this paper as Moresco et al. 2007
Citations
Cites
Functional architecture of basal ganglia circuits: neural substrates of parallel processing
Alexander, G. E., & Crutcher, M. D. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90107-l · Cited by 4,131 · cited 2×
“In particular, (a) dopamine regulates cortico-striatal-thalamo-cortical circuits through its activity on indirect and direct pathway (Alexander and Crutcher, 1990); (b) structural damages to the basal ganglia, a region particularly rich in dopamine receptors, promote OCD symptoms (Carmin et al, 2002); (c) a supersensi…”
Background3D statistical neuroanatomical models from 305 MRI volumes
Evans, A. C., Collins, D. L., Mills, S. R., Brown, E. D., Kelly, R. L., & Peters, T. M. (2005) · 1993 IEEE Conference Record Nuclear Science Symposium and Medical Imaging Conference · doi:10.1109/nssmic.1993.373602 · Cited by 1,487 · cited 1×
“Parametric images were then normalized to the Montreal Neurological Institute (MNI) stereotactic space (Evans et al, 1993) using SPM99 software (Wellcome Department of Imaging Neuroscience).”
MethodBaxter, L. R. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820090009002 · Cited by 1,293 · cited 1×
“This hypothesis is supported by neurological (Laplane et al, 1989), neurosurgical (Mindus et al, 1994; Oliver et al, 2003; Rauch, 2003), and imaging findings (Baxter et al, 1992; Breiter et al, 1996; Saxena et al, 1998; Trivedi, 1996).”
MethodEvidence for striatal dopamine release during a video game
Koepp, M. J., Gunn, R. N., Lawrence, A. D., Cunningham, V. J., Dagher, A., Jones, T., Brooks, D. J., Bench, C. J., & Grasby, P. M. (1998) · Nature · doi:10.1038/30498 · Cited by 1,279 · cited 1×
“This property of [11C]Rac binding, has been used, as an innovative strategy, to measure in living human subjects the modification in extracellular/synaptic dopamine concentration induced by pharmacological or behavioral stimulations (Laruelle, 2000b; Koepp et al, 1998).”
MethodParametric Imaging of Ligand-Receptor Binding in PET Using a Simplified Reference Region Model
Gunn, R. N., Lammertsma, A. A., Hume, S. P., & Cunningham, V. J. (1997) · NeuroImage · doi:10.1006/nimg.1997.0303 · Cited by 1,084 · cited 1×
“Radioactivity distribution images were transformed pixel by pixel into BP images and relative influx images (RI) using the RPM (reversible reference tissue model) software developed by R Gunn et al (Gunn et al, 1997).”
MethodImaging Synaptic Neurotransmission with in Vivo Binding Competition Techniques: A Critical Review
Laruelle, M. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200003000-00001 · Cited by 944 · cited 2×
“This property of [11C]Rac binding, has been used, as an innovative strategy, to measure in living human subjects the modification in extracellular/synaptic dopamine concentration induced by pharmacological or behavioral stimulations (Laruelle, 2000b; Koepp et al, 1998).”
BackgroundMethodMultimodal Image Coregistration and Partitioning—A Unified Framework
Ashburner, J., & Friston, K. (1997) · NeuroImage · doi:10.1006/nimg.1997.0290 · Cited by 927 · cited 1×
“5 (Ashburner and Friston, 1997).”
Neuroimaging and frontal–subcortical circuitry in obsessive–compulsive disorder
Saxena, S., Brody, A. L., Schwartz, J. M., & Baxter, L. R. (1998) · British Journal of Psychiatry · doi:10.1192/s0007125000297870 · Cited by 831 · cited 1×
“[11C]Rac binding has been proven to be sensitive to modification in extracellular concentration of exogenous or endogenous dopamine (Seeman et al, 1989; Laruelle, 2000a).”
BackgroundFunctional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder
Breiter, H. C. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830070041008 · Cited by 626 · cited 1×
“This hypothesis is supported by neurological (Laplane et al, 1989), neurosurgical (Mindus et al, 1994; Oliver et al, 2003; Rauch, 2003), and imaging findings (Baxter et al, 1992; Breiter et al, 1996; Saxena et al, 1998; Trivedi, 1996).”
MethodMawlawi, O., Martinez, D., Slifstein, M., Broft, A., Chatterjee, R., Hwang, D.-R., Huang, Y., Simpson, N., Ngo, K., Van Heertum, R., et al. (2001) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200109000-00002 · Cited by 525
Comparison of Methods for Analysis of Clinical [11C]Raclopride Studies
Lammertsma, A. A., Bench, C. J., Hume, S. P., Osman, S., Gunn, K., Brooks, D. J., & Frackowiak, R. S. J. (1996) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199601000-00005 · Cited by 459 · cited 1×
“[11C]Rac binding to dopamine D2 receptors was calculated using the simplified reference tissue model (Lammertsma et al, 1996).”
MethodGrace, A. A. (2000) · Addiction · doi:10.1046/j.1360-0443.95.8s2.1.x · Cited by 433 · cited 1×
“…such as amphetamine, cocaine induces some stereotypic behaviors that resemble obsessive behaviors observed in OCD patients (Goodman et al, 1990; Grace, 2000; Pitman, 1989); (b) the increase in dopamine transporter (DAT) density reported in two out of three different SPET studies on OCD…”
BackgroundLAPLANE, D., LEVASSEUR, M., PILLON, B., DUBOIS, B., BAULAC, M., MAZOYER, B., DINH, S. T., SETTE, G., DANZE, F., & BARON, J. C. (1989) · Brain · doi:10.1093/brain/112.3.699 · Cited by 415 · cited 1×
“This hypothesis is supported by neurological (Laplane et al, 1989), neurosurgical (Mindus et al, 1994; Oliver et al, 2003; Rauch, 2003), and imaging findings (Baxter et al, 1992; Breiter et al, 1996; Saxena et al, 1998; Trivedi, 1996).”
MethodLaruelle, M. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00054-5 · Cited by 358
Seeman, P., Guan, H. ‐., & Niznik, H. B. (1989) · Synapse · doi:10.1002/syn.890030113 · Cited by 293 · cited 1×
“…and monkeys indicate that SSRI reduce striatal dopamine levels (Dewey et al, 1995; Di Rocco et al, 1998; Smith et al, 2000) and some of SSRIs side effects have been associated with the reduction of striatal dopamine levels induced by their administration (Damsa et al, 2004; Shioda et al, 2004).”
BackgroundBeyond the serotonin hypothesis: a role for dopamine in some forms of obsessive compulsive disorder?
Goodman, W. K., McDougle, C. J., Price, L. H., Riddle, M. A., Pauls, D. L., & Leckman, J. F. (1990) · PubMed · Cited by 283
Wolf, S. S., Jones, D. W., Knable, M. B., Gorey, J. G., Lee, K. S., Hyde, T. M., Coppola, R., & Weinberger, D. R. (1996) · Science · doi:10.1126/science.273.5279.1225 · Cited by 252 · cited 1×
“…Publishing Group All rights reserved 0893-133X/07 $30.00 www.neuropsychopharmacology.org monozygotic twins discordant for Tourette syndrome severity (Wolf et al, 1996); and (e) a reduced availability of D2 receptors subtypes has been recently described in the left caudate nucleus of patients with…”
BackgroundInfluentialSpyraki, C., & Fibiger, H. C. (1981) · European Journal of Pharmacology · doi:10.1016/0014-2999(81)90531-8 · Cited by 239 · cited 1×
“In addition, preclinical studies on rodents indicated that the repeated administration of antidepressants affect dopamine D2 receptors (Ainsworth et al, 1998a; Ainsworth et al, 1998b; Spyraki and Fibiger, 1981).”
BackgroundDewey, S., Smith, G., Logan, J., Alexoff, D., Ding, Y., King, P., Pappas, N., Brodie, J., & Ashby, C. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-01-00821.1995 · Cited by 215 · cited 4×
“In particular, serotoninergic neurons have been found to tonically inhibit the nigrostriatal dopamine system, an effect that is probably modulated via 5HT2A receptors (Dewey et al, 1995).”
BackgroundInfluentialLow level of dopaminergic D2 receptor binding in obsessive-compulsive disorder
Denys, D., van der Wee, N., Janssen, J., De Geus, F., & Westenberg, H. G. M. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.01.023 · Cited by 195 · cited 2×
“…reserved 0893-133X/07 $30.00 www.neuropsychopharmacology.org monozygotic twins discordant for Tourette syndrome severity (Wolf et al, 1996); and (e) a reduced availability of D2 receptors subtypes has been recently described in the left caudate nucleus of patients with OCD (Denys et al, 2004).”
BackgroundResultInfluentialRauch, S. L. (2003) · Neurosurgery Clinics of North America · doi:10.1016/s1042-3680(02)00114-6 · Cited by 180 · cited 1×
“All patients were evaluated by means of structured psychiatric interview (DIS (Robins, 1989)) based on DSM-IV for Axis I diagnoses.”
MethodAssessment of Spatial Normalization of PET Ligand Images Using Ligand-Specific Templates
Meyer, J. H., Gunn, R. N., Myers, R., & Grasby, P. M. (1999) · NeuroImage · doi:10.1006/nimg.1999.0431 · Cited by 172
Sumiyoshi, T., Anil, A. E., Jin, D., Jayathilake, K., Lee, M., & Meltzer, H. Y. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145703003900 · Cited by 169
“Dopamine-Dependent” Side Effects of Selective Serotonin Reuptake Inhibitors: A Clinical Review
Damsa, C., Bumb, A., Bianchi-Demicheli, F., Vidailhet, P., Sterck, R., Andreoli, A., & Beyenburg, S. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0806 · Cited by 154 · cited 1×
“…and monkeys indicate that SSRI reduce striatal dopamine levels (Dewey et al, 1995; Di Rocco et al, 1998; Smith et al, 2000) and some of SSRIs side effects have been associated with the reduction of striatal dopamine levels induced by their administration (Damsa et al, 2004; Shioda et al, 2004).”
BackgroundKlimke, A., Larisch, R., Janz, A., Vosberg, H., Müller-Gärtner, H. W., & Gaebel, W. (1999) · Psychiatry Research Neuroimaging · doi:10.1016/s0925-4927(99)00009-8 · Cited by 136 · cited 2×
“An increased D2 receptor availability has been demonstrated in the striatum and anterior cingulate gyrus of unipolar depressed patients responders to SSRI treatment but not in nonresponder patients (Klimke et al, 1999; Larisch et al, 1997).”
(1994) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.6.4.467 · Cited by 128
Assessment of Severity and Change in Obsessive Compulsive Disorder
Goodman, W. K., & Price, L. H. (1992) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(18)30214-4 · Cited by 128 · cited 1×
“Patients were considered as fluvoxamine responders when their initial Y-BOCS scores were reduced by at least 35% (Goodman and Price, 1992; Mundo et al, 1997).”
BackgroundCocaine Addiction: Hypothesis Derived from Imaging Studies with PET
Volkow, N. D., Ding, Y.-S., Fowler, J. S., & Wang, G.-J. (1996) · Journal of Addictive Diseases · doi:10.1300/j069v15n04_04 · Cited by 120 · cited 1×
“In fact, using a similar data analysis in normal subjects, a reproducibility ranging from 7 to 8% has been reported (Volkow et al, 1996).”
MethodAnimal models of compulsive behavior
Pitman, R. K. (1989) · Biological Psychiatry · doi:10.1016/0006-3223(89)90022-x · Cited by 117 · cited 1×
“…that resemble obsessive behaviors observed in OCD patients (Goodman et al, 1990; Grace, 2000; Pitman, 1989); (b) the increase in dopamine transporter (DAT) density reported in two out of three different SPET studies on OCD patients (Cheon et al, 2004; Kim et al, 2003; Pogarell et al, 2004).”
BackgroundLarisch, R., Klimke, A., Vosberg, H., Löffler, S., Gäebel, W., & Müller-Gärtner, H.-W. (1997) · NeuroImage · doi:10.1006/nimg.1997.0267 · Cited by 116 · cited 2×
“An increased D2 receptor availability has been demonstrated in the striatum and anterior cingulate gyrus of unipolar depressed patients responders to SSRI treatment but not in nonresponder patients (Klimke et al, 1999; Larisch et al, 1997).”
BackgroundResultRole of serotonin in obsessive-compulsive disorder
Baumgarten, H. G., & Grozdanovic, Z. (1998) · British Journal of Psychiatry · doi:10.1192/s0007125000297857 · Cited by 114 · cited 1×
“The clinical efficacy of serotonin reuptake sites inhibitor (SSRI) has focused the role of serotonin and serotonin receptors in OCD (Baumgarten and Grozdanovic, 1998).”
BackgroundAinsworth, K., Smith, S. E., Zetterström, T., Pei, Q., Franklin, M., & Sharp, T. (1998) · Psychopharmacology · doi:10.1007/s002130050791 · Cited by 111 · cited 10×
“The basal firing of dopamine neuron rising from ventral tegmental area is negatively modulated by SSRIs (Di Mascio et al, 1998).”
BackgroundResultInfluentialMascio, M. D., Giovanni, G. D., Matteo, V. D., Prisco, S., & Esposito, E. (1998) · Brain Research Bulletin · doi:10.1016/s0361-9230(98)00054-9 · Cited by 107
Bilateral Anterior Capsulotomy for Refractory Obsessive-Compulsive Disorders
Oliver, B., Gascón, J., Aparicio, A., Ayats, E., Rodriguez, R., Maestro de León, J. L., García-Bach, M., & Soler, P. A. (2003) · Stereotactic and Functional Neurosurgery · doi:10.1159/000075110 · Cited by 95 · cited 1×
“Imaging studies on SSRI effect in normal subjects reported: (a) increase (Dewey et al, 1995; Penttilä et al, 2004), (b) no changes (Fowler et al, 1999), or (c) decrease (Tiihonen et al, 1996) in D2 receptors availability.”
BackgroundCheon, K. (2004) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2003.06.001 · Cited by 92 · cited 1×
“…that resemble obsessive behaviors observed in OCD patients (Goodman et al, 1990; Grace, 2000; Pitman, 1989); (b) the increase in dopamine transporter (DAT) density reported in two out of three different SPET studies on OCD patients (Cheon et al, 2004; Kim et al, 2003; Pogarell et al, 2004).”
BackgroundKim, C.-H., Koo, M.-S., Cheon, K.-A., Ryu, Y.-H., Lee, J.-D., & Lee, H.-S. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1245-7 · Cited by 82 · cited 1×
“…that resemble obsessive behaviors observed in OCD patients (Goodman et al, 1990; Grace, 2000; Pitman, 1989); (b) the increase in dopamine transporter (DAT) density reported in two out of three different SPET studies on OCD patients (Cheon et al, 2004; Kim et al, 2003; Pogarell et al, 2004).”
BackgroundThe Psychopharmacology of Obsessive Compulsive Disorder: Implications for Treatment and Pathogenesis
McDougle, C. J., Goodman, W. K., Leckman, J. F., & Price, L. H. (1993) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(18)30148-5 · Cited by 80
Treatment of late-onset OCD following basal ganglia infarct
Carmin, C. N., Wiegartz, P. S., Yunus, U., & Gillock, K. L. (2002) · Depression and Anxiety · doi:10.1002/da.10024 · Cited by 80 · cited 1×
“…(Alexander and Crutcher, 1990); (b) structural damages to the basal ganglia, a region particularly rich in dopamine receptors, promote OCD symptoms (Carmin et al, 2002); (c) a supersensitivity to cataleptic induction by the D2 receptor antagonist sulpiride was observed in the D1CT mice, an animal…”
BackgroundShioda, K., Nisijima, K., Yoshino, T., & Kato, S. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.01.013 · Cited by 63 · cited 1×
“…and monkeys indicate that SSRI reduce striatal dopamine levels (Dewey et al, 1995; Di Rocco et al, 1998; Smith et al, 2000) and some of SSRIs side effects have been associated with the reduction of striatal dopamine levels induced by their administration (Damsa et al, 2004; Shioda et al, 2004).”
BackgroundSmith, T. D., Kuczenski, R., George-Friedman, K., Malley, J. D., & Foote, S. L. (2000) · Synapse · doi:10.1002/1098-2396(20001215)38:4<460::aid-syn11>3.0.co;2-d · Cited by 60 · cited 1×
“Microdialysis studies in rats and monkeys indicate that SSRI reduce striatal dopamine levels (Dewey et al, 1995; Di Rocco et al, 1998; Smith et al, 2000) and some of SSRIs side effects have been associated with the reduction of striatal dopamine levels induced by their administration (Damsa et al,…”
BackgroundRocco, A. D., Brannan, T. S., Prikhojan, A., & Yahr, M. D. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050053 · Cited by 59
Diagnostic grammar and assessment: translating criteria into questions
Robins, L. N. (1989) · Psychological Medicine · doi:10.1017/s0033291700011028 · Cited by 59 · cited 1×
“This hypothesis is supported by neurological (Laplane et al, 1989), neurosurgical (Mindus et al, 1994; Oliver et al, 2003; Rauch, 2003), and imaging findings (Baxter et al, 1992; Breiter et al, 1996; Saxena et al, 1998; Trivedi, 1996).”
MethodPogarell, O. M., Tatsch, K., Juckel, G., Hamann, C., Mulert, C., Pöpperl, G., Folkerts, M., Choukèr, M., Riedel, M. J., Zaudig, M., et al. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300537 · Cited by 58 · cited 1×
“This hypothesis is supported by neurological (Laplane et al, 1989), neurosurgical (Mindus et al, 1994; Oliver et al, 2003; Rauch, 2003), and imaging findings (Baxter et al, 1992; Breiter et al, 1996; Saxena et al, 1998; Trivedi, 1996).”
MethodTiihonen, J., Kuoppamäki, M., Syvälahti, E. K. G., Någren, K., Eronen, E., Hietala, J. A., & Bergman, J. R. (1996) · Psychopharmacology · doi:10.1007/bf02247377 · Cited by 53 · cited 1×
“Imaging studies on SSRI effect in normal subjects reported: (a) increase (Dewey et al, 1995; Penttilä et al, 2004), (b) no changes (Fowler et al, 1999), or (c) decrease (Tiihonen et al, 1996) in D2 receptors availability.”
BackgroundLong-Term Pharmacotherapy of Obsessive-Compulsive Disorder: A Double-Blind Controlled Study
Mundo, E., Bareggi, S. R., Pirola, R., Bellodi, L., & Smeraldi, E. (1997) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199702000-00002 · Cited by 44
Self-citationFunctional neuroanatomy of obsessive-compulsive disorder.
Trivedi, M. H. (1996) · PubMed · Cited by 36
Penttilä, J., Kajander, J., Aalto, S., Hirvonen, J., Någren, K., Ilonen, T., Syvälahti, E. K. G., & Hietala, J. A. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114570400450x · Cited by 34
Ainsworth, K., Smith, S. E., & Sharp, T. (1998) · Journal of Psychopharmacology · doi:10.1177/026988119801200304 · Cited by 30 · cited 10×
“The basal firing of dopamine neuron rising from ventral tegmental area is negatively modulated by SSRIs (Di Mascio et al, 1998).”
BackgroundResultInfluentialCampbell, K. M., McGrath, M. J., & Burton, F. H. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00184-3 · Cited by 27 · cited 1×
“…was observed in the D1CT mice, an animal model that shows symptoms of human compulsive disorders associated with cortical-limbic hyperactivity (Campbell et al, 1999); (d) differences in D2 dopamine receptor binding in the head of the caudate nucleus predict phenotypic severity in Online…”
BackgroundPsychopharmacology of Obsessive-Compulsive Disorder
Montgomery, S. (1998) · CNS Spectrums · doi:10.1017/s1092852900007203 · Cited by 22
Fowler, J. S., Wang, G. J., Volkow, N. D., Ieni, J. R., Logan, J., Pappas, N. R., & Dewey, S. L. (1999) · Clinical Positron Imaging · doi:10.1016/s1095-0397(99)00028-x · Cited by 7 · cited 1×
“Imaging studies on SSRI effect in normal subjects reported: (a) increase (Dewey et al, 1995; Penttilä et al, 2004), (b) no changes (Fowler et al, 1999), or (c) decrease (Tiihonen et al, 1996) in D2 receptors availability.”
Background
Cited by
Obsessive-compulsive disorder: An integrative genetic and neurobiological perspective
Pauls, D. L., Abramovitch, A., Rauch, S. L., & Geller, D. A. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3746 · Cited by 793
Obsessive-compulsive disorder: Puzzles and prospects
Robbins, T. W., Vaghi, M. M., & Banca, P. (2019) · Neuron · doi:10.1016/j.neuron.2019.01.046 · Cited by 510
Nikolaus, S., Antke, C., Beu, M., & Müller, H.-W. (2010) · Reviews in the Neurosciences · doi:10.1515/revneuro.2010.21.2.119 · Cited by 243
Nakao, T., Okada, K., & Kanba, S. (2014) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12195 · Cited by 231
“[72] reported that [ 11 C]-Raclopride, which is a selective D2 receptor antagonist, increased the D2 binding potential significantly in the basal ganglia of OCD patients,”
Mosconi, M. W., Kay, M., D'Cruz, A.-M., Seidenfeld, A., Guter, S., Stanford, L. D., & Sweeney, J. A. (2009) · Psychological Medicine · doi:10.1017/s0033291708004984 · Cited by 222
“…be established, but observations that inhibitory control deficits are evident in both groups and are reduced by serotonergic drugs in neuropsychiatric disorders (Rosenberg et al. 2000 ; Moresco et al. 2007) suggest that frontostriatal disruption is one commonality in these behavioral disturbances.”
Background
Metadata
- Authors
- Moresco, R. M., Pietra, L., Henin, M., Panzacchi, A., Locatelli, M., Bonaldi, L., Carpinelli, A., Gobbo, C., Bellodi, L., Perani, D., & Fazio, F.
- Affiliations
- Institute of Molecular Bioimaging and Physiology (IT)
- IRCCS Ospedale San Raffaele (IT)
- Vita-Salute San Raffaele University (IT)
- Corresponding author
- Moresco, Rosa Maria
- Venue
- Neuropsychopharmacology
- Published
- 2006-10-04
- Volume
- 32
- Issue
- 1
- Pages
- 197-205
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2048998525
- Cited by
- 70
- References
- 51
- Citations by year
- 2025: 1 · 2024: 3 · 2023: 2 · 2022: 2 · 2021: 5 · 2020: 4 · 2019: 3 · 2018: 2 · 2017: 3 · 2016: 2 · 2015: 6 · 2014: 4 · 2013: 4 · 2012: 3
- FWCI
- 5.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- BOA (University of Milano-Bicocca) (submittedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- obsessive-compulsive disorder, fluvoxamine, dopamine D2 receptor, serotonin reuptake inhibitors, [11C]raclopride, basal ganglia, drug-naive patients
- MeSH terms
- Adult, Basal Ganglia, Brain Mapping, Carbon Isotopes, Female, Humans, Male, Middle Aged, Obsessive-Compulsive Disorder, Protein Binding, Tissue Distribution, Fluvoxamine, Selective Serotonin Reuptake Inhibitors, Receptors, Dopamine D2, Dopamine Antagonists, Raclopride, Positron-Emission Tomography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.